Company Filing History:
Years Active: 2002
Title: Richard Lew: Innovator in Selective Modulators of Bradykinin B2 Receptors
Introduction
Richard Lew is a notable inventor based in Hamden, Connecticut, with a focus on the development of selective modulators of bradykinin B2 receptors. He holds two patents that contribute to advancements in this field. His work is significant in the realm of pharmaceuticals and therapeutic applications.
Latest Patents
Richard Lew's latest patents include "Imidazopyridines and related derivatives as selective modulators of bradykinin B2 receptors" and "Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors." These innovations showcase his expertise in medicinal chemistry and receptor modulation.
Career Highlights
Richard Lew is associated with Neurogen Corporation, where he applies his knowledge and skills to further research and development in the pharmaceutical industry. His contributions have been instrumental in advancing therapeutic options for various medical conditions.
Collaborations
Some of Richard Lew's coworkers include Alan J Hutchison and Kenneth Shaw. Their collaborative efforts enhance the research environment and foster innovation within the company.
Conclusion
Richard Lew's work as an inventor and his contributions to the field of selective modulators of bradykinin B2 receptors highlight his importance in the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.